Intarcia, CDER Tussle Over Advisory Cmte. Process For Hearing On Denial Of Diabetes Combo Product

 
• By Brenda Sandburg
Public meeting
FDA advisory committee to consider Intarcia's application for diabetes drug implant. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers